# TRIAMTERENE
> **ANDA211581** · Abbreviated New Drug Application (Generic) · Sponsor: AGNITIO · Approved 2019-08-19
## Drug
- **FDA Application Number:** ANDA211581
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TRIAMTERENE
- **Generic name:** TRIAMTERENE CAPSULES
- **Active ingredients:** TRIAMTERENE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AGNITIO
- **Manufacturer:** TRUPHARMA LLC
- **First approval:** 2019-08-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211581)
---
*AI Analytics · CC0 1.0*